日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Case Report: Prolonged response to cabozantinib and pembrolizumab in treatment-refractory metastatic pancreatic ductal adenocarcinoma

病例报告:卡博替尼和帕博利珠单抗治疗难治性转移性胰腺导管腺癌的长期疗效

Reagan, Anna M; McDonald, Hannah G; Kang, Jaewon; Saghaeiannejad Esfahani, Hoda; Wright, Caroline G; Bailey, Charles J; Ellis, Carleton S; Collette, Kaylyn R; Patel, Reema A; Murillo, Mayte; Stokley, Samantha F; Cavnar, Michael J; Pandalai, Prakash K; Barry-Hundeyin, Mautin T; Moss, Jessica J; Kim, Joseph

Case report: Enfortumab vedotin induced refractory DKA and multi organ failure - a rare fatal adverse event

病例报告:恩福妥单抗诱发难治性糖尿病酮症酸中毒和多器官功能衰竭——罕见的致命不良事件

Kapoor, Astha Koolwal; Ellis, Carleton S; Pandey, Deepali; Allison, Derek B; Myint, Zin W

A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate Cancer

Epidiolex(大麻二酚)对生化复发性前列腺癌患者的 I 期剂量递增和扩展研究

Zin W Myint, William H St Clair, Stephen E Strup, Donglin Yan, Ning Li, Derek B Allison, Laurie E McLouth, Carleton S Ellis, Peng Wang, Andrew C James, Patrick J Hensley, Danielle E Otto, Susanne M Arnold, Robert S DiPaola, Jill M Kolesar

Correlation Between Trough Level of Abiraterone and Prostate-Specific Antigen (PSA) Response in Metastatic Hormone-Sensitive Prostate Cancer

阿比特龙谷浓度与转移性激素敏感性前列腺癌前列腺特异性抗原(PSA)反应的相关性

Myint, Zin W; Kolesar, Jill M; McCorkle, Joseph Robert; Wu, Jianrong; Ellis, Carleton S; Otto, Danielle E; Wang, Peng

Myostatin deficiency partially rescues the bone phenotype of osteogenesis imperfecta model mice

肌肉生长抑制素缺乏可部分挽救成骨不全模型小鼠的骨骼表型。

Oestreich, A K; Carleton, S M; Yao, X; Gentry, B A; Raw, C E; Brown, M; Pfeiffer, F M; Wang, Y; Phillips, C L

Direct identification and typing of Mycobacterium tuberculosis by PCR

利用PCR技术直接鉴定和分型结核分枝杆菌。

Neimark, H; Ali Baig, M; Carleton, S

Control of pT181 replication II. Mutational analysis

pT181复制的控制 II. 突变分析

Carleton, S; Projan, S J; Highlander, S K; Moghazeh, S M; Novick, R P

Control of pT181 replication I. The pT181 copy control function acts by inhibiting the synthesis of a replication protein

pT181复制的控制 I. pT181复制控制功能通过抑制复制蛋白的合成发挥作用。

Novick, R P; Adler, G K; Projan, S J; Carleton, S; Highlander, S K; Gruss, A; Khan, S A; Iordanescu, S

Coding sequence for the pT181 repC product: a plasmid-coded protein uniquely required for replication

pT181 repC 产物的编码序列:一种质粒编码的、复制所必需的蛋白质

Novick, R P; Adler, G K; Majumder, S; Khan, S A; Carleton, S; Rosenblum, W D; Iordanescu, S

Replication of plasmid pT181 DNA in vitro: requirement for a plasmid-encoded product

质粒 pT181 DNA 的体外复制:需要质粒编码产物

Khan, S A; Carleton, S M; Novick, R P